111In
111Indium (111In) is a radioisotope of indium characterized by a half-life of 2.8 days and is used in nuclear medicine for imaging and therapy. It emits both gamma radiation and Auger electrons.
Production[edit | edit source]
111In is produced in a cyclotron by the proton irradiation of cadmium. The resulting 111mCd decays to 111In by electron capture.
Medical uses[edit | edit source]
111In is used in nuclear medicine for imaging and therapy. It is used in radiopharmaceuticals such as Octreoscan (111In-DTPA-octreotide) for imaging neuroendocrine tumors, and ProstaScint (111In-capromab pendetide) for imaging prostate cancer.
Decay[edit | edit source]
111In decays by electron capture to 111Cd with a half-life of 2.8 days. The decay is accompanied by the emission of gamma radiation with energies of 171 and 245 keV, and Auger electrons.
Safety[edit | edit source]
As with all radioisotopes, handling 111In requires precautions to avoid radiation exposure. These include the use of lead shielding and radiation monitoring devices.
See also[edit | edit source]
111In Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD